Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR01213
|
|||||
| Drug Name |
Trabectedin
|
|||||
| Synonyms |
Yondelis
|
|||||
| Indication | Ovarian cancer [ICD11: 2C73] | Phase 3 | [1] | |||
| Formula |
C39H43N3O11S
|
|||||
| Canonical SMILES |
CC1=CC2=C(C3C4C5C6=C(C(=C7C(=C6C(N4C(C(C2)N3C)O)COC(=O)C8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O
|
|||||
| InChI |
InChI=1S/C39H43N3O11S/c1-16-9-20-10-22-37(46)42-23-13-50-38(47)39(21-12-25(48-5)24(44)11-19(21)7-8-40-39)14-54-36(30(42)29(41(22)4)26(20)31(45)32(16)49-6)28-27(23)35-34(51-15-52-35)17(2)33(28)53-18(3)43/h9,11-12,22-23,29-30,36-37,40,44-46H,7-8,10,13-15H2,1-6H3/t22-,23-,29+,30+,36+,37-,39+/m0/s1
|
|||||
| InChIKey |
PKVRCIRHQMSYJX-AIFWHQITSA-N
|
|||||
| CAS Number |
CAS 114899-77-3
|
|||||
| Pharmaceutical Properties | Molecular Weight | 761.8 | Topological Polar Surface Area | 194 | ||
| Heavy Atom Count | 54 | Rotatable Bond Count | 4 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 15 | |||
| XLogP |
3.4
|
|||||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:84050
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | MRP3 | Transporter Info | Multidrug resistance-associated protein 3 | Substrate | [2] | |
| References | ||||||
| 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||||
| 2 | ABCC2, ABCC3, and ABCB1, but not CYP3A, Protect against Trabectedin-Mediated Hepatotoxicity. Clin Cancer Res. 2009 Dec 15;15(24):7616-7623. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.